Application-based Animal Walking Aids segmentation reveals three distinct demand clusters. Post-surgical rehabilitation dominates, accounting for roughly 46 % of 2023 global sales; here, aids are prescribed for controlled weight-bearing during 4- to 12-week recovery windows, driving higher average selling prices because of anti-slip liners and adjustable range-of-motion joints. Chronic neuromuscular conditions—including degenerative myelopathy and fibrocartilaginous embolism—represent 34 % of revenue; these cases require long-term use, so owners gravitate toward carbon–aluminium hybrid frames that balance durability with lightness, creating a replacement cycle every 18–24 months. Finally, geriatric mobility maintenance, 20 % of the market, is price-sensitive yet volume-rich, favouring simplistic fabric-harness systems sold through farm-supply and online channels. Together, these subsegments map directly onto clinical visit frequency and pet-insurance reimbursement codes, anchoring unit-forecast models.